This technology represents an approach to explore the citrullinated proteome and peptidome in any biological sample, both qualitatively and quantitatively. It allows specific enrichment of citrullinated proteins and peptides from complex mixtures. The technology enables:
Biomarker discovery – Diagnostic tools
Technologi is open for licensing.
Mr Olav Steinnes
Inven2 AS identifies, protects and commercialises inventions and discoveries of the University of Oslo, Oslo University Hospital and other health enterprises in the south-east of Norway.View profile
Clients in focus...